Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




NA Amplification Tests for Clostridium Diagnosis Reviewed

By LabMedica International staff writers
Posted on 19 Jun 2019
Clostridioides (Clostridium) difficile infection (CDI) is the leading cause of health care-associated infections in the USA. More...
It accounts for 15% to 25% of health care-associated diarrhea cases in all health care settings, with 453,000 documented cases of CDI and 29,000 deaths in the USA in 2015.

Accurate diagnosis of CDI is critical for appropriate patient management and reduction of harms that may arise from diagnostic error and is critical for implementation of infection control measures to prevent transmission. Consequently, among patients presenting with diarrhea, there is significant potential for under diagnosis or over diagnosis as can arise from incorrect diagnostic workups.

A large team of international scientists led by those at Emory University (Atlanta, GA, USA) conducted a review of how effective newer nucleic amplification tests (NAAT) testing practices were for diagnosing patients suspected of CDI. They evaluated NAAT tests alone, which detects the toxin gene, as well as algorithmic testing (NAAT plus glutamate dehydrogenase (GDH) or toxin EIA). GDH Enzyme Immunoassay (EIA) testing detects the enzyme active in the organism, so effectively the organism, and toxin EIA detects the toxin protein. The scientists evaluated over 11,000 records found in electronic databases. 72 studies had sufficient data for meta-analysis.

The team concluded that the NAAT is the recommended practice for detecting the toxin gene. GDH/NAAT algorithm is recommended for detecting C. difficile organism/toxin gene. The overall strengths of evidence for these practices were high and effects across studies were consistent. The GDH/TOXIN/NAAT algorithm is recommended for the C. difficile organism/toxin/toxin gene, although the overall strength of evidence for this practice was moderate. The scientists had no recommendation for repeat testing using NAAT-only testing within seven days of a negative result.

Colleen Kraft, MD, MSc, the lead author of the study, said, “This study emphasizes the issues related to the diagnosis of C. difficile infection, with the focus on nucleic-acid amplification tests (NAAT). We found in this systematic review that most of the studies we looked at did not have pre-analytic and clinical outcomes data. Our hope is that future studies will consider those aspects in order to determine the utility of these tests in patient diagnosis and patient care.” The study was published on May 29, 2019, in the journal Clinical Microbiology Reviews.

Related Links:
Emory University


New
Gold Member
Hematology Analyzer
Medonic M32B
Collection and Transport System
PurSafe Plus®
New
8-Channel Pipette
SAPPHIRE 20–300 µL
New
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The study highlights the potential of cCAFs as a biomarker for early diagnosis and prognosis (H J Woo et al., Analytical Chemistry (2025). DOI: 10.1021/acs.analchem.5c02154)

Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy

Accurate cancer diagnosis remains a challenge, as liquid biopsy techniques often fail to capture the complexity of tumor biology. Traditional systems for isolating circulating tumor cells (CTCs) vary in... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.